Business Description
![Siemens Healthineers AG Siemens Healthineers AG logo](https://static.gurufocus.com/logos/0C0000BER6.png?14)
Siemens Healthineers AG
ISIN : DE000SHL1006
Share Class Description:
SEMHF: Registered SharesCompare
Compare
Traded in other countries / regions
SHL.Germany0PMJ.UKSMMNY.USA1SHL.ItalySHL.AustriaSHL.SwitzerlandSHL.Mexico IPO Date
2018-05-18Description
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.94 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.17 | |||||
Interest Coverage | 6.48 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.11 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.2 | |||||
3-Year EBITDA Growth Rate | 5.9 | |||||
3-Year EPS without NRI Growth Rate | -0.9 | |||||
3-Year FCF Growth Rate | -5.8 | |||||
3-Year Book Growth Rate | 11.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 29.19 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.09 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.35 | |||||
9-Day RSI | 11.05 | |||||
14-Day RSI | 31.8 | |||||
6-1 Month Momentum % | 5.3 | |||||
12-1 Month Momentum % | 4.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.31 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 117.72 | |||||
Days Sales Outstanding | 69.02 | |||||
Days Payable | 55.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.76 | |||||
3-Year Dividend Growth Rate | 5.9 | |||||
Forward Dividend Yield % | 1.76 | |||||
5-Year Yield-on-Cost % | 1.76 | |||||
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | 2.45 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.5 | |||||
Operating Margin % | 11.94 | |||||
Net Margin % | 8.41 | |||||
FCF Margin % | 5.47 | |||||
ROE % | 10.32 | |||||
ROA % | 4.01 | |||||
ROIC % | 5.3 | |||||
ROC (Joel Greenblatt) % | 66.79 | |||||
ROCE % | 8.43 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 32.38 | |||||
Forward PE Ratio | 19.42 | |||||
PE Ratio without NRI | 32.38 | |||||
Price-to-Owner-Earnings | 30.02 | |||||
PEG Ratio | 4.76 | |||||
PS Ratio | 2.73 | |||||
PB Ratio | 3.19 | |||||
Price-to-Free-Cash-Flow | 49.72 | |||||
Price-to-Operating-Cash-Flow | 30.89 | |||||
EV-to-EBIT | 20.67 | |||||
EV-to-Forward-EBIT | 16.46 | |||||
EV-to-EBITDA | 14.22 | |||||
EV-to-Forward-EBITDA | 13.17 | |||||
EV-to-Revenue | 2.63 | |||||
EV-to-Forward-Revenue | 2.66 | |||||
EV-to-FCF | 47.86 | |||||
Price-to-Projected-FCF | 1.88 | |||||
Earnings Yield (Greenblatt) % | 4.84 | |||||
FCF Yield % | 2.02 | |||||
Forward Rate of Return (Yacktman) % | 7.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SEMHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Siemens Healthineers AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 23,650.168 | ||
EPS (TTM) ($) | 1.772 | ||
Beta | 1.17 | ||
Volatility % | 28.61 | ||
14-Day RSI | 31.8 | ||
14-Day ATR ($) | 0.039888 | ||
20-Day SMA ($) | 57.58005 | ||
12-1 Month Momentum % | 4.69 | ||
52-Week Range ($) | 47.99 - 63.19 | ||
Shares Outstanding (Mil) | 1,118.57 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Siemens Healthineers AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Siemens Healthineers AG Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Siemens Healthineers AG Frequently Asked Questions
What is Siemens Healthineers AG(SEMHF)'s stock price today?
The current price of SEMHF is $57.36. The 52 week high of SEMHF is $63.19 and 52 week low is $47.99.
When is next earnings date of Siemens Healthineers AG(SEMHF)?
The next earnings date of Siemens Healthineers AG(SEMHF) is 2024-07-31.
Does Siemens Healthineers AG(SEMHF) pay dividends? If so, how much?
The Dividend Yield %  of Siemens Healthineers AG(SEMHF) is 1.76% (As of Today), Highest Dividend Payout Ratio of Siemens Healthineers AG(SEMHF) was 0.71. The lowest was 0.45. And the median was 0.51. The  Forward Dividend Yield % of Siemens Healthineers AG(SEMHF) is 1.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |